Design of potent human steroid 5α-reductase inhibitors: 3D-QSAR CoMFA, CoMSIA and docking studies

被引:0
|
作者
Rajnish Kumar
Priyanka Malla
Abhilasha Verma
Manoj Kumar
机构
[1] Panjab University,University Institute of Pharmaceutical Sciences
来源
关键词
5α-Reductase; Docking; Dihydrotestosterone; CoMFA; CoMSIA;
D O I
暂无
中图分类号
学科分类号
摘要
3D-QSAR CoMFA, CoMSIA and docking studies were performed on a set of 4-azasteroidal human steroid 5α-reductase inhibitors. The models developed using maximal common substructure-based alignment was found to be reliable and significant with good predictive r2 value. CoMSIA model developed using combination of steric, electrostatic, hydrophobic, hydrogen bond donor and hydrogen bond acceptor features has shown rcv2 = 0.564 with six optimum components, rncv2 = 0.945, F value = 101.196, rPred2 = 0.693 and SEE = 0.209. The contour plots obtained has shown a favourable effect of bulkier groups at C-17 position. Docking studies indicates the importance of bulkier groups at C-17 position for favourable activity. The study further helps in design of potent inhibitors of the enzyme.
引用
收藏
页码:4568 / 4580
页数:12
相关论文
共 50 条
  • [1] Design of potent human steroid 5α-reductase inhibitors: 3D-QSAR CoMFA, CoMSIA and docking studies
    Kumar, Rajnish
    Malla, Priyanka
    Verma, Abhilasha
    Kumar, Manoj
    [J]. MEDICINAL CHEMISTRY RESEARCH, 2013, 22 (10) : 4568 - 4580
  • [2] 3D-QSAR CoMFA and CoMSIA studies for design of potent human steroid 5α-reductase inhibitors
    Kumar, Rajnish
    Kumar, Manoj
    [J]. MEDICINAL CHEMISTRY RESEARCH, 2013, 22 (01) : 105 - 114
  • [3] 3D-QSAR CoMFA and CoMSIA studies for design of potent human steroid 5α-reductase inhibitors
    Rajnish Kumar
    Manoj Kumar
    [J]. Medicinal Chemistry Research, 2013, 22 : 105 - 114
  • [4] 3D-QSAR (CoMFA, CoMSIA) and Molecular Docking Studies on Histone Deacetylase 1 Selective Inhibitors
    Abdizadeh, Tooba
    Ghodsi, Razieh
    Hadizadeh, Farzin
    [J]. RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2017, 12 (04) : 365 - 383
  • [5] CoMFA/CoMSIA 3D-QSAR of pyrimidine inhibitors of Pneumocystis carinii dihydrofolate reductase
    Santos-Filho, Osvaldo A.
    Forge, Delphine
    Hoelz, Lucas V. B.
    de Freitas, Guilherme B. L.
    Marinho, Thiago O.
    Araujo, Jocley Q.
    Albuquerque, Magaly G.
    de Alencastro, Ricardo B.
    Boechat, Nubia
    [J]. JOURNAL OF MOLECULAR MODELING, 2012, 18 (09) : 4061 - 4072
  • [6] 3D-QSAR studies of Checkpoint Kinase Weel inhibitors based on molecular docking, CoMFA and CoMSIA
    Yi, Ping
    Fang, Xin
    Qiu, Minghua
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2008, 43 (05) : 925 - 938
  • [7] CoMFA/CoMSIA 3D-QSAR of pyrimidine inhibitors of Pneumocystis carinii dihydrofolate reductase
    Osvaldo A. Santos-Filho
    Delphine Forge
    Lucas V. B. Hoelz
    Guilherme B. L. de Freitas
    Thiago O. Marinho
    Jocley Q. Araújo
    Magaly G. Albuquerque
    Ricardo B. de Alencastro
    Nubia Boechat
    [J]. Journal of Molecular Modeling, 2012, 18 : 4061 - 4072
  • [8] 3D-QSAR Analysis of MCD Inhibitors by CoMFA and CoMSIA
    Pourbasheer, Eslam
    Aalizadeh, Reza
    Ebadi, Amin
    Ganjali, Mohammad Reza
    [J]. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2015, 18 (08) : 751 - 766
  • [9] 3D-QSAR CoMFA/CoMSIA Studies, to Design New VEGFR-2 Inhibitors
    Batouche, S.
    Gheid, A.
    [J]. ASIAN JOURNAL OF CHEMISTRY, 2011, 23 (01) : 206 - 214
  • [10] Molecular docking and 3D-QSAR studies of falcipain inhibitors using CoMFA, CoMSIA, and Open3DQSAR
    Ghasemi, Jahan B.
    Shiri, Fereshteh
    [J]. MEDICINAL CHEMISTRY RESEARCH, 2012, 21 (10) : 2788 - 2806